GlassScriptPhysician profile
Sarah M Mendon
NPI 1265055313
$975.97
in general payments reported to CMS, 2019-2025
9 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.14 · 2023: $107 · 2024: $238 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.83 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $239.66 | 2025 | Repatha |
| Medtronic, INC. | $154.94 | 2023-2025 | Aurora Ev-Icd Mri Surescan |
| Abiomed | $141.55 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $125.00 | 2025 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $123.89 | 2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.15 | 2024 | Lifevest |
| Medline Industries LP | $53.39 | 2023 | |
| Philips North America LLC | $28.25 | 2025 | Extended Holter |
| Bioventus LLC | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Mendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.